| Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017 | 3786 | 2017 |
| Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study MJ Titulaer, L McCracken, I Gabilondo, T Armangué, C Glaser, T Iizuka, ... The Lancet Neurology 12 (2), 157-165, 2013 | 3324 | 2013 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2469 | 2019 |
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ... Nature genetics 43 (5), 436-441, 2011 | 2213 | 2011 |
| Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ... New England Journal of Medicine 370 (4), 322-333, 2014 | 2172 | 2014 |
| Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 11934, 2016 | 1078 | 2016 |
| Aggregation of vascular risk factors and risk of incident Alzheimer disease JA Luchsinger, C Reitz, LS Honig, MX Tang, S Shea, R Mayeux Neurology 65 (4), 545-551, 2005 | 1048 | 2005 |
| Trial of solanezumab for mild dementia due to Alzheimer’s disease LS Honig, B Vellas, M Woodward, M Boada, R Bullock, M Borrie, K Hager, ... New England Journal of Medicine 378 (4), 321-330, 2018 | 1046 | 2018 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 959 | 2017 |
| Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease DP Devanand, G Pradhaban, X Liu, A Khandji, S De Santi, S Segal, ... Neurology 68 (11), 828-836, 2007 | 950 | 2007 |
| A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease S Salloway, R Sperling, S Gilman, NC Fox, K Blennow, M Raskind, ... Neurology 73 (24), 2061-2070, 2009 | 924 | 2009 |
| Interplay of LRRK2 with chaperone-mediated autophagy SJ Orenstein, SH Kuo, I Tasset, E Arias, H Koga, I Fernandez-Carasa, ... Nature neuroscience 16 (4), 394-406, 2013 | 673 | 2013 |
| Neuropathological changes in essential tremor: 33 cases compared with 21 controls ED Louis, PL Faust, JPG Vonsattel, LS Honig, A Rajput, CA Robinson, ... Brain 130 (12), 3297-3307, 2007 | 651 | 2007 |
| RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson’s disease risk DA MacLeod, H Rhinn, T Kuwahara, A Zolin, G Di Paolo, BD McCabe, ... Neuron 77 (3), 425-439, 2013 | 631 | 2013 |
| Comparative lipidomic analysis of mouse and human brain with Alzheimer disease RB Chan, TG Oliveira, EP Cortes, LS Honig, KE Duff, SA Small, MR Wenk, ... Journal of Biological Chemistry 287 (4), 2678-2688, 2012 | 622 | 2012 |
| Plasma Aβ40 and Aβ42 and Alzheimer’s disease: relation to age, mortality, and risk R Mayeux, LS Honig, MX Tang, J Manly, Y Stern, N Schupf, PD Mehta Neurology 61 (9), 1185-1190, 2003 | 599 | 2003 |
| Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis R Sperling, S Salloway, DJ Brooks, D Tampieri, J Barakos, NC Fox, ... The Lancet Neurology 11 (3), 241-249, 2012 | 542 | 2012 |
| Research criteria for the diagnosis of prodromal dementia with Lewy bodies IG McKeith, TJ Ferman, AJ Thomas, F Blanc, BF Boeve, H Fujishiro, ... Neurology 94 (17), 743-755, 2020 | 536 | 2020 |
| Plasma tau in Alzheimer disease N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ... Neurology 87 (17), 1827-1835, 2016 | 514 | 2016 |
| Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ... Archives of neurology 67 (12), 1473-1484, 2010 | 514 | 2010 |
